A B S T R A C T We examined the role of microtubules in platelet aggregation and secretion (release reaction) induced by the calcium ionophore A23187 (0. 8-5 ,uM). At these concentrations, platelet aggregation was preceded by a lag period of -1 min. Colchicine (an agent that disrupts microtubule assembly-disassembly) was shown to bind to platelet microtubules by employing [3H]colchicine at a concentration that is specific for microtubules in other tissues (10 nM). Colchicine prolonged the lag period, inhibited the secondary wave of platelet aggregation, and inhibited the release reaction (release of[14C]serotonin). Platelets were next incubated with 20-60% D20, an agent that stabilizes microtubules. D20 overcame colchicineinduced inhibition of the lag period, aggregation, and release. D20 alone enhanced platelet aggregation by 59+14% (SEM) and shortened the lag period by 43+10%. We conclude that functioning microtubules are required for platelet aggregation and release, and that microtubules of platelet preparations are functioning submaximally.
INTRODUCTION
The platelet is a cell whose major physiologic function, formation of a firm hemostatic plug, requires primary platelet aggregation by physiologic aggregating agents (collagen, ADP, thrombin, epinephrine); secretion of platelet contents (release reaction); and the irreversible secondary wave of platelet aggregation. This is accompanied by a change in platelet shape from disk to sphere (1) . The secondary wave of platelet aggregation is preceded by, or associated with (2) , the secretion of various platelet constituents such as ADP, Ca', 284 and serotonin, which contribute to further propagation of the platelet plug. In other tissues, secretory events have been closely associated with microtubules (3, 4) . Little is known of this association in platelets.
The role of microtubules has been postulated to be that of a supporting structure that helps maintain the platelet discoid shape (5) . Its possible role in platelet secretion can be inferred from other studies using platelet aggregating agents and electron microscopy (6) . A centripetal movement of circumferential microtubules and platelet granules before the release reaction has been described. Irreversible secondary platelet aggregation and release wvere associated with the apparent disappearance of centrally located microtubules (7) . The secondary wave of platelet aggregation (induced by ADP or epinephrine) could be inhibited by "toxic" concentrations (1 mM) of antimicrotubule agents that cause the apparent disappearance of microtubules under electron microscopy (7, 8) , and that have additional properties other than their inhibition of microtubule assembly (9) (10) (11) (12) (13) (14) (15) (16) .
The purpose of this investigation was to study the role of microtubules in platelet aggregation induced by the Ca++ ionophore A23187, as well as other aggregating agents, with concentrations of antimicrotubule agents that are specific for microtubules. The Ca++ ionophore was employed because internal as well as external translocations of calcium are thought to trigger internal contractile events, as well as platelet release and aggregation (17, 18) , and serotonin release from platelets by the Ca++ ionophore has some characteristics of the physiologic release reaction (17) .
METHODS
Platelet-rich plasma (PRP)1for platelet aggregation studies.
ingested any drugs for at least 1 wk. Whole blood was collected into 3.8% trisodium citrate (nine parts plus one part) in plastic tubes and centrifuged at 150 g for 5 min at room temperature in a desktop International centrifuge (International Equipment Co., Boston, Mass.). PRP was kept at room temperature for 30 min in tightly capped plastic tubes and then e(luilibrated at 37°C for 3 min before testinig. Platelet-poor plasma was obtained by centrifuging the remainder of the blood at 2,000 g for 20 min.
Aggregating agents. The aggregating agents used were dissolved in saline and diluted with 0.03 M veronal buffer and 0.13 M NaCl, pH 7.4, in a volume of 50 1Al. Final 2 ,500g for 15 min at 40C, resuspended in 30 ml of 1% ammonium oxalate, and allowed to sit at room temperature for 10 min. The platelets were then resedimented and washed with 10 ml of Tris-buffered saline, pH 7.4, containing 0.14 M NaCl, 0.015 M tris-HCI, and 5.5 mnM glucose (20) ; resuspended in 1 ml of buffer (5-10% volume suspension); and incubated in 17 x 100-mM polypropylene tul)es (Falcon Labware, Div. of Becton, Dickinson, and Co., Oxnard, Calif.) at 37°C, in the presence of [3H]colchicine, 1 x 106 cpm/ml, for 60 min.
Preparation of platelet cytoplasm. The platelets were sedimented at 2,000 g for 15 min at 4°C and washed three times with 10 ml of buffer. Platelets were resuspended in 1 ml of buffer and sonicated at 0°C with a Sonifier Cell Disruptor (Heat System.s-Ultrasonics, Inc., Plainview, N. Y.) at maximal intensity for two 15-sec periods. The sonicated platelets were then centrifuged at 100,000 g for 1 h at 4°C, using a Beckman model L Ultracentrifuge.
Molecular wveight determination of protein bound to tritiated colchicine. The extract prepared above was applied to a calibrated Sephacryl S-200 gel filtration column (Pharmacia Diagnostics, Div. of Pharmnacia, Inc., Piscataway, N. J.) and the molecular weight of the tritiated protein peak was determined with protein molecular weight standards (21): immunoglobulin (155,000), bovine serum albumin (68,000), ovalbumin (43,000), and carbonic anhydrase (29,000). Protein was monitored by 280 Aim absorbance.
[3H]Colchicine was assayed for radioactivity by scintillation counting.
Polyacrylamide gel electrophoresis of tritiated colchicine peakfraction. The fraction conitaining the peak radioactivity was concentrated by ultrafiltration under vacuum and electrophoresed under nondenaturing conditions. The gel was 7 cm long, 0.6 cm in diameter, and composed of 10% polyacrylamide with 0.28% cross-linkage in 0.1 M phosphate buffer, pH 7.0. The procedure of Weber and Osborn (22) was followed, except for the absence of sodium dodecyl sulfate, using a Pharmacia gel electrophoresis apparatus, 
RESULTS
Effect of colchicine on platelet aggregation induced by ADP, epinephrine, and collagen. Fig. la, b , and c demonstrate the inhibitory effect of preincubation of 0.25-2 mM colchicine for 2 min on platelet aggregation induced by ADP, epinephrine, or collagen, confirming initial observations of White (7) as well as others (23, 24) . As can be noted, this inhibition affects the secondary wave of platelet aggregation more than the primary wave.
Effect of colchicine or vinblastine on platelet aggregation induced by Ca++ ionophore A23187. Calcium ionophore-induced platelet aggregation at <5 ,uM was preceded by a lag period which in all studies was followed by a single wave ofplatelet aggregation. Binding of 10 nM colchicine to platelet tubulin. Platelets were incubated in the presence of 10 nM tritiated colchicine, 1 million cpm/ml, for 1 h, and the cell sap was prepared as cited in Methods. 1 ml of the cell sap was applied to a calibrated (U) Sephacryl-200 gel filtration column, 1.0 x 28 cm, and the effluent (0.5-ml fractions) monitored for radioactivity (0) and 280 ,um absorbance (0). Peak radioactivity was obtained at an apparent molecular weight of 110,000. Free tritiated colchicine peaked at tube number 94.
increased the lag period by 33+2.5% (Five experiments, P < 0.001). The effect of both colchicine and vinblastine was additive (Table I) . Effect of D20 and colchicine on platelet aggregation and release of serotonin induced by Ca++ ionophore A23187. D20, an agent known to stabilize microtubules in other tissues, shortened the Ca++ ionophore-induced lag period by 43+10% and increased the velocity of platelet aggregation by 59+14% (P < 0.05) at a D20 concentration of60% (average of seven experiments). Similar changes were noted at 40% (P < 0.05) and 20% (P < 0.01) D20 (Table II) . The combination of D20 and colchicine apparently corrected the alkaloid-induced inhibition of platelet aggregation velocity and prolonged the lag period (Table  II) . For example, 2 mM colchicine inhibited the H20 control by 35% (P < 0.001), whereas inhibition (16%) was negligible in the presence of 30% D20 (P < 0.1). Similar results were obtained with the lag period (data not shown). 7 .0. The gel was fixed, frozen, sliced, monitored for radioactivity, and compared with a similar gel on which a purified brain tubulin standard was applied (inset). The two radioactive (-) monomer components oftubulin, a and ,, were electrophoresed at the same position as purified brain tubulin standard. Effect of 10 or 100 nM colchicine on platelet aggregation and release. Since colchicine at 0.1 mM does not inhibit platelet aggregation after 2 min of preincubation, we examined the possible effect of longer preincubation at lower colchicine concentration on platelet aggregation and release. Fig. 3 demonstrates that after preincubation for 1 h, 10 nM colchicine does inhibit platelet aggregation, compared with a control incubation.2 D20 alone shortened the lag period and enhanced aggregation velocity. D20 plus colchicine completely overcame the inhibition of 10 nM colchicine (representative of five experiments). In similar experiments, low concentration of colchicine (0.1 ,uM) also inhibited platelet release of serotonin.(Lumicolchicine an agent that does not bind tubulin, at 0.1 ,uM had no effect). D20 plus colchicine overcame this inhibition (Table III, experiment 7) . Lysis of serotoninloaded control platelets in D20 buffer gave similar 2 It is of interest to note that 0.5 AM colchicinie has been
shown to inhibit platelet spreading on glass slides (25) .
release, as did lysis of serotonin-loaded platelets in H20 buffer. Binding of 10 nM colchicine to platelet tubulin. Since 10 nM colchicine does not lead to disassembly of microtubules in platelets, as indicated by electron microscopy, whereas 0.1-1.0 mM colchicine does (7), we examined whether colchicine at 10 nM binds to platelet tubulin. Platelets were therefore incubated in the presence of [3H]colchicine and the cell sap applied to a calibrated Sephacryl-200 gel filtration column. Fig. 4 demonstrates that the peak radioactivity was obtained at a molecular weight of 110,000, that of tubulin dimer. This peak of radioactivity was then concentrated by filtration under vacuum, applied to a nondenaturing 10% polyacrylamide gel, and electrophoresed in 0.1 M phosphate buffer at pH 7.0. The gel was frozen and sliced, and the distribution of radioactivity was compared with a brain tubulin standard simultaneously run. The two monomer components of tubulin, a and /3, coelectrophoresed at the same position as purified brain tubulin standard (Fig. 5) .
DISCUS SION
The role of microtubules in platelet aggregation has been relegated to that of a supporting structure, maintaining the platelet's discoid shape (5) . In other tissues, inhibition of microtubule assembly impairs secretory events (3, 4) . Previous work by White (7), employing toxic doses of alkaloids, revealed impaired platelet aggregation, particularly secondary aggregation. These toxic doses (0.1-1.0 mM) were required for the disappearance of platelet microtubules, as indicated by electron microscopy. However, the pharmocologic dosage of colchicine used in the treatment of gout is in the 1-,uM range, and concentrations of 10 ,uM are fatal (26) . Furthermore, in vitro concentrations ofcolchicine in the 10-1000 ,utM-range are known to affect other cellular processes (9) (10) (11) (12) (13) (14) (15) (16) .
It was therefore necessary to determine whether colchicine impairs platelet aggregation by reacting with microtubules, and whether colchicine also inhibits platelet secretion. This was accomplished by three approaches. First, concentrations of colchicine were employed that were fairly specific for microtubules in other tissues (27, 28) . Platelets were incubated with colchicine at 10 and 100 nM for 60 min before addition of the aggregating agent, Ca++ ionophore A23187. This dose was also noted to inhibit secretion of platelet serotonin. Second, D20, a known stabilizer of microtubules, nullified the colchicineinduced inhibition of platelet aggregation and secretion. Furthermore, 60% D20 alone also enhanced by 59% platelet aggregation induced by Ca++ ionophore and reduced the lag period by 43%. These data suggest that microtubules of platelet preparations are functioning submaximally. Third, [3H]colchicine at 10 nM was shown to bind specifically to platelet microtubules when incubated with intact platelets.
Thus, colchicine, which binds to platelet microtubules at concentrations that are specific for microtubules, inhibits secondary platelet aggregation and secretion. Microtubules therefore not only provide a supporting structure for platelet discoid shape, but are also necessary for secondary platelet aggregation and secretion.
